Abstract Background Coronavirus disease 2019 (COVID-19) is a respiratory disease
associated with endotheliitis and microthrombosis. Objectives To correlate endothelial …

Background Several studies have reported that the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) can directly infect endothelial cells, and endothelial …

Increase in thrombotic and microvascular complications is emerging to be a key feature of
patients with critical illness associated with COVID-19 infection. While endotheliopathy is …

To the Editor: Previous studies suggested that the endothelial dysfunction is associated with
the severity and mortality of patients affected by coronavirus disease 2019 (COVID-19) …

Background: Endotheliopathy is a key element in COVID-19 pathophysiology, contributing to
both morbidity and mortality. Biomarkers distinguishing different COVID-19 phenotypes from …

Background COVID-19 infection is characterised, among other features, by a prothrombotic
state with high rate of venous thromboembolism (VTE), D-dimer, and fibrinogen levels …

Background An important feature of severe acute respiratory syndrome coronavirus 2
pathogenesis is COVID-19-associated coagulopathy, characterised by increased thrombotic …

Endothelial cell (EC) activation plays a key role in the pathogenesis of pulmonary
microvascular occlusion, which is a hallmark of severe coronavirus disease 2019 (COVID …

Background Immunothrombosis and coagulopathy in the lung microvasculature may lead to
lung injury and disease progression in coronavirus disease 2019 (COVID‐19). We aim to …

Abstract Background Coronavirus disease-2019 (COVID-19), a respiratory disease has
been associated with ischemic complications, coagulation disorders, and an endotheliitis …